JOHNSON & JOHNSON — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-02-14

Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-15	Common Stock	M	15806.0000	$0.0000	Acquired	48054.9545	Direct
2022-02-15	Common Stock	F	6242.0000	$165.8900	Disposed	41812.9545	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-14	Employee Stock Options (Right to Buy)	$	A	66110.0000	Acquired	2032-02-14	Common Stock (66110.0000)	Direct
2022-02-14	Restricted Share Units	$	A	3347.0000	Acquired		Common Stock (3347.0000)	Direct
2022-02-15	Performance Share Units	$	M	15806.0000	Disposed		Common Stock (15806.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2607.0000	Indirect
Common Stock	300.0000	Indirect

Footnotes

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

F2: Shares withheld for payment of taxes upon vesting of Performance Share Units.

F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).

F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).

F5: Awarded under Issuer's Long-Term Incentive Plan.

F6: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.

F7: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.